Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.
Andy Dang, PharmD Candidate
Advertisement
Andy Dang is a PharmD candidate at the University of Houston College of Pharmacy in Texas.
Articles by Andy Dang, PharmD Candidate
Advertisement
Latest Updated Articles
Finerenone and the Future of Diabetes-Related Kidney CarePublished: July 15th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Celebrating the Pharmacist’s Impact: How Pharmacists Elevate Care in Every Setting
3
FDA Approves 1-Minute HIV Self-Test
4
How Pharmacists Can Navigate Legal Complexities With Most Favored Nation Status
5
